Good entry point. This stock is definitely able to explode and has proved consistently to have a history of success. I believe that all the trials will be successful especially SG-110. SG-110 is simply an amplified version of dacogen that the company has specifically stated in press releases and conference calls is eager to present data. Not to mention anyone knowing anything about the small cap biotech sector knows that stocks usually run into the upcoming data with or without success. There is a lot of money to be made here, enjoy the ride.
Market Data 
Markets 
AI
